Structural carcinoma overall process: a systematic review

AR Arabestanino, SS Naghibi Irvani, A Ai… - Cellular, Molecular …, 2024 - cmbr-journal.com
Abnormalities of several oncogenes and tumor suppressor genes have been identified in
carcinomas during the last decade and of pathological warfare and physiological traits, and …

Dynamic Nomogram Based on the Metastatic Number and Sites and Therapy Strategies Predicting the Prognosis of Patients with Metastatic Cervical Cancer

Y Ma, J Li, X Tan, M Cai, X Zhang… - International Journal of …, 2022 - Taylor & Francis
Background Individual survival prediction is of vital importance to optimize the individualized
treatment of metastatic cervical cancer (mCC) patients. The goal of this study was to identify …

[HTML][HTML] A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

ME Buyukbayram, Z Hannarici, A Turhan, AA Caglar… - BMC …, 2024 - ncbi.nlm.nih.gov
Background Cervical cancer is a tumor with high morbidity and mortality. The importance of
inflammatory and metabolic parameters affecting progression-free survival (PFS) and overall …

Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2)

S Li, H Zhang, Y Jiao, X Song, L Wei, X Liu - Bioengineered, 2022 - Taylor & Francis
Oxymatrine (OMT) has exhibited an anti-cancer role in human cancers, including cervical
cancer (CC). The dysregulated circular RNAs (circRNAs) are key regulators in cancer …

Treatment for locally resectable stage IIIC1 cervical Cancer: a retrospective, single-Institution Study

Y Kashima, K Murakami, C Miyagawa, H Takaya… - Healthcare, 2023 - mdpi.com
According to the revision of the FIGO 2018 staging system, cervical cancer with pelvic lymph
node metastases was changed to stage IIIC1. We retrospectively analyzed the prognosis …

[HTML][HTML] Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?

M Zhong, Y Liu, J Yang, Y Wang, M Ao, Y Xiao, S Zeng… - BMC cancer, 2024 - Springer
Objective The aim of this study was to compare the therapeutic value and treatment-related
complications of radical hysterectomy with those of concurrent chemoradiotherapy (CCRT) …

Prognostic Factors Analysis of Metastatic Recurrence in Cervical Carcinoma Patients Treated with Definitive Radiotherapy: A Retrospective Study Using Mixture Cure …

X Ou, J You, B Liang, X Li, J Zhou, F Wen, J Wang… - Cancers, 2023 - mdpi.com
Simple Summary Definitive chemoradiotherapy is the standard treatment for locally
advanced cervical carcinoma. The risk of local recurrence is usually low for cervical …

Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy

W Zhang, H Yu, Y Xiu, F Meng… - … in Cancer Research …, 2024 - journals.sagepub.com
Objective: Since the update of the 2018 International Federation of Gynecology and
Obstetrics (FIGO) staging criteria, there have been few reports on the prognosis of stage III C …

FIGO 2018 IIIC 期宫颈癌的预后及治疗策略

马杏, 刘畅 - 协和医学杂志, 2024 - xhyxzz.pumch.cn
肿瘤分期和淋巴结受累是局部晚期宫颈癌最重要的预后因素. 对于宫颈癌,
妇科肿瘤医师普遍应用国际妇产科联盟(InternationalFederation of Gynecology and Obstetrics …

Cervical cancer screening among female refugees in Jordan: A cross-sectional study

N Muhaidat, MA Alshrouf, RN Alshajrawi, ZR Miqdadi… - Healthcare, 2022 - mdpi.com
Background: Cervical cancer (CC) is mainly linked to infection with a high-risk oncogenic
human papillomavirus (HPV), with 85% of deaths occurring in developing countries …